(Q50974429)

English

Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder.

scientific article published in December 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

0 references

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

Andrew R. Lloyd

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

7

object named as

McConaghy N

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

author name string

O'Donnell MC

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

Catts SV

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

Liebert B

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

Wakefield D

6

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

language of work or name

0 references

publication date

1 December 1996

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

Psychiatry Research

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

65

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

171-178

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokines in neuronal cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum Interferon in First Psychotic Attack

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine production and lymphocyte transformation during stress

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoimmunity in schizophrenia: a review of recent findings

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased interleukin-2 production in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine-receptor-stimulating autoantibodies: a possible cause of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of interleukin 2 in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for interleukin-2 in the regulation of striatal dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptom monitoring in the rehabilitation of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular immunity in schizophrenic patients before and during neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Communications among central nervous system, neuroendocrine and immune systems: interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Is interleukin 2 a neuromodulator in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated levels of soluble interleukin 2 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The soluble interleukin-2 receptor: biology, function, and clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated soluble interleukin-2 receptors in young healthy cigarette smokers: lack of association with atopy or airways hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble interleukin-2 receptors in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2896%2902824-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0165-1781(96)02824-7

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/9029665

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50974429&oldid=1754400221"